Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update

Go back to Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update
(NASDAQ: ACXP) Delayed: 1.57 -0.08 (4.85%)
Previous Close $1.65    52 Week High
Open $1.63    52 Week Low
Day High $1.65    P/E N/A 
Day Low $1.56    EPS
Volume 52,199